Effectiveness of tuberculosis preventive treatment on disease incidence among people living with HIV/AIDS: A systematic review and meta-analysis
Open Access
- 26 August 2025
- journal article
- review article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (8) , e0330208
Abstract
Background: Clinical trials have shown the protective efficacy of tuberculosis preventive treatment (TPT) for averting disease and death from tuberculosis among people living with HIV/AIDS (PLHIV). TPT has been recommended for PLHIV since the 1980s. However, tuberculosis is still the first cause of death in PLHIV. Objective: We aimed to summarize the evidence related to the real-world effectiveness of TPT on tuberculosis incidence among PLHIV. Method: This is a systematic review and meta-analysis of observational cohort studies. The search was carried out in PubMed (via MEDLINE), Embase, LILACS, Scopus and Web of Science databases. Free and controlled vocabulary was used for the searches, with no restrictions on language or publication period. Studies reporting hazard ratios (HR) for tuberculosis incidence among PLHIV who received TPT were pooled using random-effects meta-analysis models. Meta-regression was performed to assess whether study-level characteristics accounted for heterogeneity, as evaluated by Cochran’s I² statistic. Study quality was appraised using the Newcastle-Ottawa Scale. This study was registered with PROSPERO (CRD42024586273). Results: Among 8,330 screened studies, 34 were included, with nine contributing to the meta-analysis. TPT was associated with a 63% reduction in tuberculosis incidence risk (HR = 0.37, 95% CI: 0.28–0.48; I² = 43%). Children exhibited consistent stronger protection (82% risk reduction, HR = 0.18, 0.09–0.37; I² = 0%) than adults (56% reduction, HR = 0.44, 0.37–0.53; I² = 21%). Conclusion: In real world conditions, TPT significantly and substantially reduces tuberculosis incidence in PLHIV, with consistent evidence of stronger protective effects in children. Despite some heterogeneity among adult studies, the pooled evidence confirms the protective effectiveness previously observed in clinical trials. These findings reinforce the global recommendation for broad implementation of TPT among PLHIV.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de NÃvel Superior (001)
This publication has 51 references indexed in Scilit:
- Effectiveness of preventive treatment among different age groups and Mycobacterium tuberculosis infection status: a systematic review and individual-participant data meta-analysis of contact tracing studiesThe Lancet Respiratory Medicine, 2024
- Screening for tuberculosis infection and effectiveness of preventive treatment among people with HIV in low-incidence settingsAIDS, 2023
- Drop‐offs in the isoniazid preventive therapy cascade among children living with HIV in western Kenya, 2015–2019Journal of the International AIDS Society, 2022
- Effectiveness of a 6-Month Isoniazid on Prevention of Incident Tuberculosis Among People Living with HIV in Eritrea: A Retrospective Cohort StudyInfectious Diseases and Therapy, 2022
- Chronic Immune Activation in TB/HIV Co-infectionTrends in Microbiology, 2020
- A longitudinal study on latent TB infection screening and its association with TB incidence in HIV patientsScientific Reports, 2019
- Effect of isoniazid preventive therapy on tuberculosis incidence in people living with HIV-AIDS at Hasan Sadikin hospitalIOP Conference Series: Earth and Environmental Science, 2018
- Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohortAIDS, 2009
- Meta-analysis of Observational Studies in EpidemiologyA Proposal for ReportingJAMA, 2000
- Effectiveness of isoniazid chemoprophylaxis for HIV-infected drug users at high risk for active tuberculosisAIDS, 1999